BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9206193)

  • 1. [Clinical trial of an anti-fertility method with testosterone enanthate in normal men].
    Cao J; Yuan J; Jin W
    Zhonghua Yi Xue Za Zhi; 1996 May; 76(5):335-7. PubMed ID: 9206193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of spermatogenesis by testosterone enanthate in Thai men.
    Aribarg A; Sukcharoen N; Chanprasit Y; Ngeamvijawat J; Kriangsinyos R
    J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive efficacy and adverse effects of testosterone enanthate in Thai men.
    Sukcharoen N; Aribarg A; Kriangsinyos R; Chanprasit Y; Ngeamvijawat J
    J Med Assoc Thai; 1996 Dec; 79(12):767-73. PubMed ID: 9071080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
    Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
    J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate.
    Anderson RA; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):896-901. PubMed ID: 8772547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception.
    Brady BM; Walton M; Hollow N; Kicman AT; Baird DT; Anderson RA
    Hum Reprod; 2004 Nov; 19(11):2658-67. PubMed ID: 15333595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men.
    World Health Organization Task Force on Methods for the Regulation of Male Fertility
    Fertil Steril; 1996 Apr; 65(4):821-9. PubMed ID: 8654646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility.
    Lancet; 1990 Oct; 336(8721):955-9. PubMed ID: 1977002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
    J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the acceptability of an injectable hormonal method for men.
    Ringheim K
    Fam Plann Perspect; 1995; 27(3):123-8. PubMed ID: 7672104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men.
    Gu Y; Liang X; Wu W; Liu M; Song S; Cheng L; Bo L; Xiong C; Wang X; Liu X; Peng L; Yao K
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1910-5. PubMed ID: 19293262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. V. Localization of higher 5 alpha-reductase activity to the reproductive tract in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Kelly RW; Wu FC
    J Androl; 1997; 18(4):366-71. PubMed ID: 9283948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraception in men: efficacy and immediate toxicity. A study of 18 cases.
    Lobel B; Olivo JF; Guille F; Le Lannou D
    Acta Urol Belg; 1989; 57(1):117-24. PubMed ID: 2718834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligozoospermia induced by exogenous testosterone is associated with normal functioning residual spermatozoa.
    Wang C; Leung A; Superlano L; Steiner B; Swerdloff RS
    Fertil Steril; 1997 Jul; 68(1):149-53. PubMed ID: 9207601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for partial suppression of spermatogenesis of hormonal male contraception.
    Li JW; Gu YQ
    Asian J Androl; 2008 Sep; 10(5):723-30. PubMed ID: 18645675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in research into new methods of fertility regulation for men.
    Prog Hum Reprod Res; 1995; (33):2. PubMed ID: 12289975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of testosterone-induced suppression to severe oligozoospermia or azoospermia in two multinational clinical studies. World Health Organization Task force on Methods for The Regulations of Male Fertility.
    Int J Androl; 1995 Jun; 18(3):157-65. PubMed ID: 7558380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.